Status:
UNKNOWN
EEG Monitoring in the Emergency Department
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Brigham and Women's Hospital
Conditions:
Drug Overdose
Substance Abuse
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to investigate whether drug effects in suspected overdose patients could be identified using the electroencephalogram (EEG). From previous work it is known that different classes of a...
Eligibility Criteria
Inclusion
- Adult patients aged 18 years and older who present to the ED with suspected use of a potential drug of abuse
Exclusion
- Hemodynamic instability or other acute medical condition for which the primary treating team does not thing it would be appropriate or safe for the study staff to approach the patient
- The patient has an overt head trauma or deformity of the face which would preclude application of the forehead EEG monitoring lead
- The patient has dermatological issues or skin conditions on the forehead
- The patient has known dementia and/or mental impairment
- The patient is a prisoner
- The patient is an employee or student at one of the study sites.
Key Trial Info
Start Date :
September 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04070521
Start Date
September 6 2019
End Date
October 31 2024
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114